Long term effect of switching to darunavir/ritonavir in HIV infected patients previously on protease inhibitor therapy

Braz J Infect Dis. 2016 Jul-Aug;20(4):401-2. doi: 10.1016/j.bjid.2016.02.002. Epub 2016 Mar 8.
No abstract available

Publication types

  • Letter

MeSH terms

  • Cholesterol, LDL / blood
  • Darunavir / administration & dosage*
  • Darunavir / adverse effects
  • Drug Substitution
  • HIV Infections / drug therapy*
  • HIV Protease Inhibitors / administration & dosage*
  • HIV Protease Inhibitors / adverse effects
  • HIV-Associated Lipodystrophy Syndrome / blood
  • HIV-Associated Lipodystrophy Syndrome / chemically induced*
  • Humans
  • Prospective Studies
  • Ritonavir / administration & dosage*
  • Ritonavir / adverse effects
  • Triglycerides / blood

Substances

  • Cholesterol, LDL
  • HIV Protease Inhibitors
  • Triglycerides
  • Ritonavir
  • Darunavir